Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 8, 1998, Pages 435-443

  Dunn, Theresa A ^a   Schmoll, Hans Joachim ^a   Rie, Christoph ^b   Hartmann, Kristin ^b   Casper, Jochen ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Germ cell cancer; Human; Nude mice

Indexed keywords

CELL SURFACE MARKER; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; HEMATOPOIETIC PEPTIDE GROWTH FACTOR; INTERLEUKIN 6; PLATINUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GERM CELL TUMOR; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NON SEMINOMATOUS GERMINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; GERMINOMA; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INTERLEUKIN-6; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MICE, NUDE; STEM CELL FACTOR; TESTICULAR NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031711427     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050196     Document Type: Article

References (60)

1. Andrews PW, Bronson DL, Benham F, Strickland S, Knowles BB (1980) A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 26:269-280
2. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J-I, Keitz A von, Looijenga LHJ, Millan JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebaek NE, van Putten W, Stern P (1996) Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumors. Int J Cancer 66:806-816
3. Bast RC Jr, Boyer CM, Xu FJ, Wiener J, Dabel R, Woolas R, Jacobs I, Berchuck A (1995) Molecular approaches to prevention and detection of epithelial ovarian cancer. J Cell Biochem Suppl 23:219-222
4. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martinez-Maza O (1991) Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 164:1038-1043
5. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, Bachvarova RF (1993) The kit-ligand (steel factor) and its receptor c-kit W: pleiotropic roles in gametogenesis and melanogenesis. Dev Supp 125
6. Blay JY, Negrier S, Combaret V, Attali S, Goillet E, Merrouch Y, Mercatello A, Ravault A, Tourani J-M, Moskovtchenko J-F, Philip T, Favrot M (1992) Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma Cancer Res 52:3317
7. Bokemeyer C, Schmoll HJ, Casper J, Kuczyk M, Poliwoda H. (1993) No growth stimulation of helerotransplanted human testicular cancer cell lines by recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Int J Oncol 3:77-80
8. Bokemeyer C, Kuczyk MA, Dunn T, Serth J, Hartmann K, Jonasson J, Pietsch T, Jonas U, Schmoll HJ (1996) Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumors. J Cancer Res Clin Oncol 122:301-310
9. Briddell R, Hartley CA, Smith KA, McNiece IK (1993) Recombinant rat stem cell factor synergises with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilise peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720
10. Briddell R, Glaspy J, Shpall EJ, LeMaistre F, Menchaca D, McNiece I (1994) Mobilisation of myeloid, erythroid and megakaryocyte progenitors by recombinant human stem cell factor (rhSCF) plus Filgrastim (rh-G-CSF) in patients with breast cancer. Proc Am Assoc Clin Oncol Annu Meet ASCO 13:109
11. Bronson DL, Andrews PW, Solter D, Cervenka J, Lange PH, Fraley EE (1980) Cell line derived from a metastasis of a human testicular germ cell tumor. Cancer Res 40:2500-2506
12. Bronson DL, Andrews PW, Vassella RL, Fraley EE (1983) In vitro differentiation of human embryonal carcinoma cells. In: Silver LM, Martin GR, Stickland S (eds) Teratocarcinoma stem cells. CSH conference on cell proliferation. New York, pp 597-605
13. Bronson DL, Vessella RL, Fraley EE (1984) Differentiation potential of human embryonal carcinoma cell lines. Cell Differ 15:129-132
14. Burger RA, Grosen EA, Ioli GR, Van Eden ME, Park M, Berman ML, Marietta A, Disaia PJ, Granger GA, Gatanaga (1995) Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumour cell populations purified from human ovarian carcinoma. J Interferon Cytokine Res 15:255-260
15. Casper J, Schmoll H-J, Schnaidt U, Fonatsch C (1987) cell lines of human germinal cancer. Int J Androl 10:105-113
16. Chaganti RSK, Bosl GJ (1995) Germ cell tumors: unraveling a biological paradox. Lab Invest 73:593-595
17. Chambers SK, Wang Y, Gertz, RE, Kacinski M (1995) Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 55:1578-1585
18. Dunn TA, Schmoll HJ, Grunwald V, Casper J, Bokemeyer C (1997a) Pre-clinical activity of taxol in non-scminomatous germ cell tumor cell lines and nude mouse xenografts. Invest New Drugs 15:91-98
19. Dunn TA, Schmoll H-J, Grünwald V, Bokemeyer C (1997b). Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. Invest New Drugs 15:109-114
20. Freireich EG, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anti-cancer agents in mouse, rat, horse, dog, monkey and man. Cancer Chemother Rep 50:219
21. Glaspy J, McNiece I, LeMaistre F, Menchaca D, Briddell R, Lill M, Jones R, Taml J, Morstyn G, Brown S, Shpall EJ (1994) Effects of stem cell factor (rhSCF) and filgrastim (rhG-CSF) on mobilisation of peripheral blood progenitor cells (PBPC) and on hematological recovery posttransplant: early results from a phase I/II study. Proc Am Assoc Clin Oncol Annu Meet 13:76
22. Harstrick A, Casper J, Guba R, Wilke H, Poliwoda H, Schmoll HJ (1989) Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro. Cancer 63:1079-1083
23. Harstrick, A, Schmoll HJ, Casper J, Wilke H, Poliwoda H (1990) Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents. Eur J Cancer 26:898-901
24. Hayashi E, Rikimaru K, Nagayama M (1995) Simultaneous production of G-and M-CSF by an oral cancer cell line and the synergistic effects on associated leucocytosis. Eur J Cancer B Oral Oncol 31B:323-327.
25. Huebner K, Isobe M, Croce CM, Golde DW, Kaufman SE, Gasson JC (1985) The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q-anomaly. Science 230:1282
26. Kikuchi T, Nakahara S, Abe T (1996) Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth. J Neurooncol 27:31-38
27. Kiss C, Cesano A, Zsebo KM, Clark SC, Santoli D (1993). Human stem cell factor (c-Kit ligand) induces an autocrine loop of growth in a Gm-CSF-dependent megakaryocytic leukemia cell line. Leukemia 7(2):235
28. Koshimizu U, Taga T, Watanabe M, Saito M, Shirayoshi Y, Kishimoto T, Nakatsuji N (1996) Functional requirement of gp 130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells. Development 122:1235-1242
29. Lang SH, Miller WR, Duncan W, Habib FK (1994) Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59:235-241
30. Lotem J, Sachs (1994) Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ 5:321-327
31. McNiece I, Langley K, Zsebo K (1991) Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226
32. Mizutani Y, Okada Y, Terachi T, Kakehi Y, Yoshida O (1995) Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumor and various urological malignancies Br J Urol 76:580-586
33. Monti E, Szymczuk S, Motta MR, Benini C, Gattori PP, Pini E, Pasquini E, Zoli W, Amadori D, Ravaioli A (1993) GM-CSF production in human adenocarcinoma cell lines. J Boil Regul Homeost Agents 7:85-91
34. Murty VVVS, Houldsworth J, Baldwin S, Reuter V, Hunziker W, Besmer P, Bosl G, Changanti RSK (1992) Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci USA 89:11 006-11 010
35. Niesvizky R, Siegel D, Michaeli J (1993) Biology and treatment of multiple myeloma. Blood Rev 7:24
36. Nitta T, Sato K, Allegretta M, Brocke S, Lim M, Mitchell DJ, Steinman L (1992) Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 571:19-25
37. Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klinger P, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B (1995) IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7:542-547
38. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T, Suzuki T (1996) Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophaaeal squamous cell carcinoma. Cancer Res 56:2776-2780
39. Okada K, Shimizu Y, Nambu S, Higuchi K, Watanabe A (1994) Interleukin 6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 9:462-467
40. Okuda Y, Morris PL (1994b) Identification of Interleukin-6 receptor (IL-6R) mRNA in isolated Sertoli and Leydig cells: regulation by gonadotropin and interleukins in vitro. Endocrine 2:1163-1168
41. Okuda Y, Xiao-Rong S, Morris PL (1994a) Interleukin-6 (IL-6) mRNAs expressed in Leydig and Sertoli cells are regulated by cytokines gonadotropins and neuropeptides. Endocrine 2:617-624
42. Papadimitriou CA, Topp MS, Serve H, Oelmann E, Koenigsmann M, Maurer J, Oberberg D, Reufi B, Thiel E, Berdel WE (1995) Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. Eur J Cancer 31A:2371-2378
43. Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB (1996) Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 16:557-563
44. Saltman DL, Dolganov GM, Hinton LM, Lovett M (1992) Reassignment of the human macrophage colony stimulating factor gene to chromosome 1p13-21. Biochem Biophys Res Commun 182:1139
45. Simmers RN, Webber LM, Shannon MF, Garson OM, Wong G, Vadas MA, Sutherland GR (1987) Localisation of the G-CSF gene on chromosome 17 proximal to the breakpoint t(15; 17) in acute promyelocytic leukemia. Blood 70:330
46. Skakkabaek NE (1972) Possible Carcinoma-in-situ of the testis. Lancet 2:516
47. Skakkabaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 10:19
48. Skehan P, Storeng R, Scudiero D, Monks A, McMahan J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82:1107-1112
49. Söder O, Bergh A, Granholm T, Pöllanen P, Euler M von, Gustafsson K, Söderquist C, Lundström C, Arver S, Parvinen M, Rizen EM (1991) In: Hormonal communicating events in the testis. pp 106-113
50. Speirs V, Green AR, White MR (1996) A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer 66:551-556
51. Tartour E, Gey A, Sastre-Garau X, Pannetier C, Mosseri V, Kourilsky P, Fridman WH (1994) Analysis of interleukin-6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin-6 gene expression in invasive carcinoma. Cancer Res 54:6243-6248
52. Turner AM, Bennett LG, Lin NL, Wypych J, Bantley TD, Hont RW, Atkins HL, Langley KE, Parker V, Martin F, Broody V (1995) Identification and characterisation of a soluble c-kit receptor produced by human hematopoeitic cell lines. Blood 85: 2052-2058
53. Tsukada M, Nagahara T, Yago T, Matsuda H, Yanoma S (1993) Production of granulocyte-colony-stimulating factor by head and neck carcinomas. Biotherapy 6(5):183-187
54. Vogelzang NJ, Bronson DL, Savino D, Vassella R, Fraley EF (1985) A human embryonalyolk sac carcinoma model system in athymic nude mice. Cancer 55:2584-2593
55. Wang N, Trend B, Bronson DL, Fraley EE (1980) Nonrandom abnormalities in chromosome I in human testicular cancers. Cancer Res 40:796-802
56. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza, O (1990) Constitutive production of interleukin 6 by by ovarian cancer cell lines and primary ovarian tumor cultures. Cancer Res 50:6959-6965
57. Weaver A, Ryder D, Crowther D, Dexter TM, Testa NG (1996) Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomised to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood 88:3323-3328
58. Witte ON (1990) Steel locus defines new multipotent growth factor. Cell 63:5-6
59. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK, Chi CW (1996) Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91:1417-1422
60. Wylie CC, Heasman J (1993) Migration, Proliferation, and potency of primordial germ cells. Sem in Dev Biol 4:161-170